Type of pending procedure.
Out of the 2,158 patients, 700 (32.4%) were DM. Figure 1 shows the type of pending procedure in patients with and without DM. Coronary diagnostic and/or therapeutic intervention was the most frequent pending procedure both groups of patients, but it was more frequent in DM than in non-DM (61.5% vs. 49.5%, respectively; p < 0.001). The second type of procedure was percutaneous valvular intervention, that accounted for 17.9% and 16.2% for DM and non-DM, respectively (p = 0.300). Other diagnostic procedure was pending in 14.2% and 25.2% of DM and non-DM patients, respectively (p < 0.001). Other therapeutic procedure was pending in 6.7% and 9.1% in patients with and without DM, respectively (p = 0.060).
Comparison of patients with and without DM.
Table 1 shows the differences among patients with and without DM related with clinical characteristics. Patients with DM were older, and had a higher prevalence of hypertension, hypercholesterolemia, chronic renal failure, peripheral artery disease, and previously diagnosed coronary artery disease including previous infarction, and previous myocardial revascularization both percutaneous and surgical. Left ventricular dysfunction was more frequently present in patients with DM. Functional class for heart failure (NYHA) was similar for patients with and without DM, but functional class for angina (CCS) was worse for patients with DM.
Table 1
Clinical characteristics of patients with and without DM. CAD: coronary artery disease. PCI: Percutaneous coronary intervention. CABG: Coronary artery bypass grafting. NYHA: New York Heart Association. CCS: Cardiology Canadian Society.
|
DM
|
|
|
Yes
(n = 691)
|
No
(1,419)
|
P value
|
Age
|
72.3 ± 10.0
|
69.2 ± 12.7
|
< 0.001
|
Age ≥ 80 (%)
|
24.9
|
21.4
|
0.078
|
Female gender (%)
|
34.9
|
39.9
|
0.066
|
Hypertension (%)
|
82.9
|
59.8
|
< 0.001
|
Hypercholesterolemia (%)
|
71.0
|
47.9
|
< 0.001
|
Smoking (%)
|
30.8
|
29.3
|
0.483
|
Chronic renal failure (%)
|
13.2
|
7.5
|
< 0.001
|
Peripheral artery disease (%)
|
14.2
|
9.0
|
< 0.001
|
Previous CAD (%)
|
41.7
|
27.4
|
< 0.001
|
Previous infarction (%)
|
17.9
|
11.4
|
< 0.001
|
Previous PCI (%)
|
23.6
|
15.5
|
< 0.001
|
Previous CABG (%)
|
6.7
|
3.4
|
0.001
|
Previous valve replacement (%)
|
3.5
|
4.9
|
0.144
|
Left ventricular dysfunction (%)
|
27.1
|
21.4
|
0.033
|
NYHA > II (%)
|
20.1
|
19.0
|
0.282
|
CCS > II (%)
|
10.0
|
8.4
|
0.001
|
Main cardiovascular condition (%)
Ischemic heart disease
Valvular heart disease
Other
|
57.6
29.2
13.3
|
47.0
36.9
16.2
|
< 0.001
|
Among the 2,158 patients, 559 had previously documented coronary artery disease. Patients with DM had higher frequency of multi-vessel disease (72.9% vs. 56.7% in non-DM, p < 0.001). Left main disease was also more frequent in patients with DM, but differences were not statistically significant (13.9% vs. 9.8% in non-DM, p = 0.133).
Influence of DM on clinical outcomes.
During the 45-day follow-up period, 36 patients died (1.7%), most of them due to cardiovascular causes (n = 19, 59.4%). Patients with DM had a higher rate of both overall mortality (3.0% vs. 1.0% in non-DM, p = 0.001) and cardiovascular mortality (1.9% vs. 0.4% in non-DM, p = 0.001), whereas differences in non-cardiovascular mortality were not statistically different (1.1% vs 0.6% in DM and non-DM, respectively; p = 0.196).
In the multivariable analysis, DM remained as an independent risk factor both for overall and cardiovascular mortality (Fig. 2).
The proportion of patients that underwent an urgent procedure due to clinical instabilization was also significantly higher in patients with DM (10.4% vs. 7.3% in non-DM; p = 0.015).
During the study period, 12 patients with DM (2.3%) and 21 without DM (1.4%) had a diagnosis of COVID-19 by protein-chain reaction test for SARS-CoV-2 (p = 0.157).
Mortality in patients with and without DM among different subgroups.
Mortality and cardiovascular mortality were higher in patients with DM regardless the main cardiovascular disease, although differences were statistically significant only for those patients with valvular heart disease (Figs. 3.A and 3.B).
Figure 4 shows the mortality and cardiovascular mortality in patients with and without DM in the most frequent types of pending procedures. Mortality and cardiovascular mortality were higher in patients pending on coronary diagnostic or therapeutic procedures, TAVI, and other diagnostic procedures, but differences reached statistical significance only for cardiovascular mortality in patients pending on TAVI. In patients pending on LAAC, mortality was higher in non-DM but differences were not statistically different.
Tables 2 and 3 show the overall and cardiovascular mortality in patients with and without DM in different patient subgroups accordingly to clinical characteristics. No significant interaction was found between DM and other clinical variables (Table 4).
Table 2
Mortality in patients with and without DM in different patients subgroups. PCI: Percutaneous coronary intervention. CABG: Coronary artery bypass grafting. NYHA: New York Heart Association. CCS: Cardiology Canadian Society.
|
Factor present
|
|
Yes
|
No
|
|
DM
|
Non-DM
|
P value
|
DM
|
Non-DM
|
P value
|
Age > 80 (%)
|
7.5
|
3.8
|
0.071
|
1.5
|
0.3
|
0.006
|
Female gender (%)
|
5.0
|
1.2
|
0.001
|
2.0
|
0.9
|
0.098
|
Hypertension (%)
|
3.3
|
1.1
|
0.003
|
0.0
|
0.7
|
0.362
|
Hypercholesterolemia (%)
|
3.3
|
1.2
|
0.012
|
1.5
|
0.7
|
0.378
|
Smoking (%)
|
1.0
|
0.2
|
0.262
|
3.4
|
1.2
|
0.004
|
Chronic renal failure (%)
|
9.9
|
2.8
|
0.036
|
2.0
|
0.9
|
0.044
|
Peripheral artery disease (%)
|
3.1
|
3.1
|
1.000
|
3.0
|
0.8
|
< 0.001
|
Previous CAD (%)
|
2.4
|
1.8
|
0.537
|
3.0
|
0.7
|
0.001
|
Previous infarction (%)
|
2.4
|
0.6
|
0.314
|
3.1
|
1.1
|
0.002
|
Previous PCI (%)
|
2.4
|
0.4
|
0.165
|
3.2
|
1.1
|
0.003
|
Previous CABG (%)
|
0.0
|
6.3
|
0.242
|
3.2
|
0.9
|
< 0.001
|
Previous valve replacement (%)
|
4.3
|
1.5
|
0.444
|
2.6
|
0.8
|
0.002
|
Left ventricular dysfunction (%)
|
1.6
|
0.7
|
0.370
|
3.2
|
1.0
|
0.001
|
NYHA > 2 (%)
|
7.1
|
2.5
|
0.061
|
2.1
|
0.7
|
0.014
|
CCS > 2 (%)
|
4.8
|
3.9
|
1.000
|
2.7
|
0.7
|
0.001
|
Table 3
Cardiovascular mortality in patients with and without DM in different patients subgroups. PCI: Percutaneous coronary intervention. CABG: Coronary artery bypass grafting. NYHA: New York Heart Association. CCS: Cardiology Canadian Society.
|
Factor present
|
|
Yes
|
No
|
|
DM
|
Non-DM
|
P value
|
DM
|
Non-DM
|
P value
|
Age > 80 (%)
|
4.6
|
1.9
|
0.093
|
1.0
|
0.0
|
0.003
|
Female gender (%)
|
4.1
|
0.5
|
0.001
|
0.7
|
0.3
|
0.409
|
Hypertension (%)
|
2.3
|
0.5
|
0.002
|
0.0
|
0.2
|
1.000
|
Hypercholesterolemia (%)
|
2.0
|
0.6
|
0.023
|
1.5
|
0.1
|
0.032
|
Smoking (%)
|
0.5
|
0.0
|
0.335
|
2.3
|
0.5
|
0.002
|
Chronic renal failure (%)
|
7.7
|
1.9
|
0.083
|
1.0
|
0.3
|
0.079
|
Peripheral artery disease (%)
|
0.0
|
0.0
|
1.000
|
2.2
|
0.5
|
< 0.001
|
Previous CAD (%)
|
1.4
|
0.5
|
0.244
|
2.3
|
0.4
|
0.002
|
Previous infarction (%)
|
0.8
|
0.6
|
1.000
|
2.1
|
0.4
|
< 0.001
|
Previous PCI (%)
|
1.8
|
0.4
|
0.312
|
1.9
|
0.4
|
0.004
|
Previous CABG (%)
|
0.0
|
2.1
|
1.000
|
2.0
|
0.4
|
< 0.001
|
Previous valve replacement (%)
|
4.3
|
0.0
|
0.253
|
1.7
|
0.4
|
0.002
|
Left ventricular dysfunction (%)
|
1.1
|
0.7
|
0.635
|
2.2
|
0.4
|
0.001
|
NYHA > 2 (%)
|
5.1
|
1.2
|
0.049
|
1.6
|
0.2
|
0.004
|
CCS > 2 (%)
|
3.2
|
2.9
|
1.000
|
1.8
|
0.2
|
< 0.001
|
Table 4
Interaction between different variables and the effect of diabetes on mortality and cardiovascular mortality.
|
P for interaction
|
|
Mortality
|
Cardiovascular mortality
|
Age > 80 (%)
|
0.192
|
0.990
|
Female gender (%)
|
0.353
|
0176
|
Hypertension (%)
|
0.996
|
0.996
|
Hypercholesterolemia (%)
|
0.774
|
0.375
|
Smoking (%)
|
0.799
|
0.994
|
Chronic renal failure (%)
|
0.499
|
0.790
|
Peripheral artery disease (%)
|
0.128
|
1.000
|
Previous CAD (%)
|
0.102
|
0.478
|
Previous infarction (%)
|
0.774
|
0.361
|
Previous PCI (%)
|
0.550
|
0.950
|
Previous CABG (%)
|
|
|
Previous valve replacement (%)
|
0.976
|
0.997
|
Left ventricular dysfunction (%)
|
|
|
NYHA > 2 (%)
|
0.953
|
0.561
|
CCS > 2 (%)
|
0.212
|
0.066
|